» Articles » PMID: 32296783

Significance of Interleukin (IL)-15 in IgE Associated Eosinophilic Esophagitis (EoE)

Overview
Date 2020 Apr 17
PMID 32296783
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Aim: IgE-mediated immune responses contribute to the pathogenesis of eosinophilic esophagitis (EoE). Interleukin (IL)-4 is a well-established cytokine involved in B cell activation, immunoglobulin (Ig) E production and isotype class switching. Earlier reports indicated that IL-15, B cells and IgE are induced in EoE pathogenesis. Therefore, we hypothesized that induced IL-15 and IgE may have a significant correlation in promoting EoE pathogenesis.

Methods: Accordingly, we performed ELISA, qPCR, flowcytometric and immunostaining analyses to examine IgE, B cells, eosinophils and mast cells in the esophagus of IL-15 overexpressed mice following EoE induction.

Results: Herein, we show that IL-15 overexpressed mice indeed have induced baseline IL-4, B cells, eosinophils, mast cells and IgE levels in the blood and esophagus. Further, we observed that IL-15 overexpressed mice show induction of IgE, and accumulation of degranulated eosinophils and mast cells in allergen-induced experimental EoE. Notably, despite induced blood IgE, esophageal eosinophilia is not induced in intestinal fatty acid binding protein IL-15 overexpressed gene (Fabpi-IL-15) mice. Fabpi-IL-15 transgenic mice showed IgE in the blood and intestine and intestinal eosinophilia, but no esophageal eosinophilia at baseline and comparable eosinophils in the esophagus of saline and allergen challenged Fabpi-IL-15 mice. Similarly, allergen challenged gene-deficient mice show reduced IgE and esophageal eosinophilia in allergen-induced experimental EoE.

Conclusions: Taken together, we for the first time provide direct evidence that tissue-specific IL-15 induced IgE mediated responses, not systemic IgE is critical in promoting EoE pathogenesis.

Citing Articles

From Pathogenesis to Treatment: Targeting Type-2 Inflammation in Eosinophilic Esophagitis.

Barchi A, Mandarino F, Yacoub M, Albarello L, Massimino L, Savarino E Biomolecules. 2024; 14(9).

PMID: 39334846 PMC: 11429508. DOI: 10.3390/biom14091080.


Type 2 Inflammation in Eosinophilic Esophagitis: From Pathophysiology to Therapeutic Targets.

Racca F, Pellegatta G, Cataldo G, Vespa E, Carlani E, Pelaia C Front Physiol. 2022; 12:815842.

PMID: 35095572 PMC: 8790151. DOI: 10.3389/fphys.2021.815842.


Blood mRNA levels of T cells and IgE receptors are novel non-invasive biomarkers for eosinophilic esophagitis (EoE).

Upparahalli Venkateshaiah S, Rayapudi M, Kandikattu H, Yadavalli C, Mishra A Clin Immunol. 2021; 227:108752.

PMID: 33945873 PMC: 8215583. DOI: 10.1016/j.clim.2021.108752.


Tacrolimus (FK506) treatment protects allergen-, IL-5- and IL-13-induced mucosal eosinophilia.

Kandikattu H, Upparahalli Venkateshaiah S, Verma A, Mishra A Immunology. 2021; 163(2):220-235.

PMID: 33512727 PMC: 8114213. DOI: 10.1111/imm.13314.

References
1.
Mishra A, Hogan S, Lee J, Foster P, Rothenberg M . Fundamental signals that regulate eosinophil homing to the gastrointestinal tract. J Clin Invest. 1999; 103(12):1719-27. PMC: 408388. DOI: 10.1172/JCI6560. View

2.
Mishra A, Schlotman J, Wang M, Rothenberg M . Critical role for adaptive T cell immunity in experimental eosinophilic esophagitis in mice. J Leukoc Biol. 2006; 81(4):916-24. DOI: 10.1189/jlb.1106653. View

3.
Noti M, Tait Wojno E, Kim B, Siracusa M, Giacomin P, Nair M . Thymic stromal lymphopoietin-elicited basophil responses promote eosinophilic esophagitis. Nat Med. 2013; 19(8):1005-13. PMC: 3951204. DOI: 10.1038/nm.3281. View

4.
Jyonouchi S, Smith C, Saretta F, Abraham V, Ruymann K, Modayur-Chandramouleeswaran P . Invariant natural killer T cells in children with eosinophilic esophagitis. Clin Exp Allergy. 2013; 44(1):58-68. PMC: 3926503. DOI: 10.1111/cea.12201. View

5.
Spergel J . Eosinophilic esophagitis in adults and children: evidence for a food allergy component in many patients. Curr Opin Allergy Clin Immunol. 2007; 7(3):274-8. DOI: 10.1097/ACI.0b013e32813aee4a. View